Chemours (CC) Operating Expenses (2014 - 2026)

Chemours' Operating Expenses history runs 13 years deep, the most recent figure standing at $186.0 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 1.64% year-over-year to $186.0 million; the TTM figure through Mar 2026 stood at $969.0 million (up 15.77% YoY), while the FY2025 annual figure was $966.0 million, up 17.38% from the prior year.
• Operating Expenses was $186.0 million for Q1 2026 at Chemours, up from $161.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $806.0 million in Q2 2023 to a low of $152.0 million in Q3 2025.
• Historically, Operating Expenses has averaged $256.9 million across 5 years, with a median of $186.0 million in 2026.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses surged 187.86% in 2023, then slumped 77.3% in 2024.
• A 5-year view of Operating Expenses shows it stood at $211.0 million in 2022, then increased by 21.8% to $257.0 million in 2023, then fell by 20.62% to $204.0 million in 2024, then declined by 21.08% to $161.0 million in 2025, then advanced by 15.53% to $186.0 million in 2026.
• The last three Operating Expenses figures came in at $186.0 million (Q1 2026), $161.0 million (Q4 2025), and $152.0 million (Q3 2025), per Business Quant data.